Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sagripanti

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Minerva Medica|October 25, 2001
Plasma platelet activating factor in nephrotic syndromeM Camici, A Sagripanti
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|November 21, 2000
[Uremic coagulopathy. Role of thrombin]M Camici, A Sagripanti
Experimental Gerontology|February 10, 1999
Natural anticoagulants, aging, and thromboembolismA Sagripanti, A Carpi
Nephron|January 1, 1997
Bleeding and thrombosis in chronic uremiaA Sagripanti, G Barsotti
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 12, 2000
Antithrombotic and prothrombotic activities of the vascular endotheliumA Sagripanti, A Carpi
Minerva Medica|July 1, 1999
Tissue factor pathway inhibitorM Camici, A Sagripanti
Minerva Medica|September 11, 2002
[Cardiovascular prevention: new biochemical plasmatic markers of risk]M Camici, A Sagripanti
Nephron|January 1, 1995
Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndromeA Sagripanti, G Barsotti
Thyroidology|January 1, 1991
The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: preliminary dataA Sagripanti, A Carpi, U Baicchi
Nephron|January 1, 1997
Low-molecular-weight heparin and lipoprotein(a) in patients with chronic renal failureA Sagripanti, V Cozza, G Barsotti
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Minerva Medica|October 25, 2001
Plasma platelet activating factor in nephrotic syndromeM Camici, A Sagripanti
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|November 21, 2000
[Uremic coagulopathy. Role of thrombin]M Camici, A Sagripanti
Experimental Gerontology|February 10, 1999
Natural anticoagulants, aging, and thromboembolismA Sagripanti, A Carpi
Nephron|January 1, 1997
Bleeding and thrombosis in chronic uremiaA Sagripanti, G Barsotti
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 12, 2000
Antithrombotic and prothrombotic activities of the vascular endotheliumA Sagripanti, A Carpi
Minerva Medica|July 1, 1999
Tissue factor pathway inhibitorM Camici, A Sagripanti
Minerva Medica|September 11, 2002
[Cardiovascular prevention: new biochemical plasmatic markers of risk]M Camici, A Sagripanti
Nephron|January 1, 1995
Hypercoagulability, intraglomerular coagulation, and thromboembolism in nephrotic syndromeA Sagripanti, G Barsotti
Thyroidology|January 1, 1991
The measurement of plasma D-dimer in the follow-up after thyroidectomy for cancer: preliminary dataA Sagripanti, A Carpi, U Baicchi
Nephron|January 1, 1997
Low-molecular-weight heparin and lipoprotein(a) in patients with chronic renal failureA Sagripanti, V Cozza, G Barsotti
Pageof 7